Nicotinamide riboside + exercise
2 papers2 findings
- 2 independent labs in 1 country
- Funders: National Institutes of Health and 7 more
- Human trial2
Outcomes
2Peak VO2
upin humans1
1 study
Peak VO2
upin humans1
Nicotinamide riboside + exercise increases peak VO2 in humans (0.21 L/min, 95% CI 0.05 to 0.36, padjusted=0.0299).
“0·21 (0·05 to 0·36; padjusted=0·0299) for nicotinamide riboside and exercise in combination”
Human trialFriedreich's ataxia12 weeksn = 66
The Lancet. Neurology17 Apr 2026
Daytime systolic blood pressure
no changein humans1
1 study
Daytime systolic blood pressure
no changein humans1
Nicotinamide riboside + exercise has no effect on daytime systolic blood pressure in humans (5.19 ± 13.2 vs - 2.71 ± 10.5 mmHg).
“NR + Ex (mean change = 5.19 ± 13.2 mmHg) did not reduce SBP more than PL + Ex (- 2.71 ± 10.5 mmHg).”
Human trialhypertension6 weeksn = 54
GeroScience7 Aug 2025
Latest
1 in 12 monthsGeroScience
Nicotinamide riboside combined with exercise to treat hypertension in middle-aged and older adults: a pilot randomized clinical trial
Randomised trial in 54 peopleNicotinamide riboside